SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: phbolton who wrote (216)6/17/1999 4:07:00 PM
From: LLCF  Read Replies (3) of 523
 
Penner on "Bloomberg" audio with an interview on the license deal...

- use the money to further drug discovery and bring product to market.
- company is developing a business plan to take the technology to other companies on a "selective basis". Not staffed to market this thing, nor does it sound like they will.
- PFE expects to dramatically reduce their discovery time, and streamline their process.
- lame question about earnings estimates... will come in under burn estimates [duhh?]... when will you turn a profit?? [duhh]... "Thats a moving target".
- 3 to 4 years to get a product on the market.
- Deal doesn't include NRGN's libraries... hasn't sold off any of it's drug discovery assets.

DAK

PS... his outfit was "hideous"... isn't that a plus?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News